Trial to Evaluate the Use of Pomegranate Concentrate (POMx) for the Prevention of Experimental Rhinovirus Infection

Completed · Phase 2 · Has a placebo group

Conditions studied: Common Cold

In brief

Pomegranate has a long history of use in folk medicine. There is vast data on the health benefits of pomegranate fruit and juice. Multiple studies have established the strong antioxidative effects of pomegranate polyphenols (primarily the ellagitannin punicalagin) and their health effects. A vast number of animal and human clinical studies have provided evidence on effect of pomegranate products on reducing symptoms of common cold, reducing blood pressure, improving endothelial function, anti-tumor activity, and its anti-atherosclerotic activity. This study will evaluate the protective effect of a pomegranate concentrate (POMx) in decreasing the incidence and duration of the common cold among healthy adults.

Key facts

Study ID

NCT00655031

Run by

POM Wonderful LLC

People needed

150

Starts

2008-04-01

Expected to finish

2008-07-01

Last updated by the study team

2008-08-18

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Nonsmoker
• No recent history of respiratory disease

You may not qualify if…

• Serum positive for rhinovirus
• Pregnant or breastfeeding
• Recent immunization

Where it is running

• Accelovance Inc. — Huntsville, Alabama, United States
• Accelovance Inc — Melbourne, Florida, United States
• University of Virginia School of Medicine — Charlottesville, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.